The neurofibromatoses: Classification, clinical features and genetic counselling

Monographs in Human Genetics

Volumn 16, Issue , 2008, Pages 1-20

  Huson, S M ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLOMUS;

EID: 84870227493     PISSN: 00770876     EISSN: 16623835     Source Type: Book Series    
DOI: 10.1159/000126500     Document Type: Review

References (56)

1. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, et al: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51-57. (Pubitemid 27274517)
2. Huson SM, Korf BR: The Phakomatoses; in Rimoin DL, Connor JM, Pyeritz RE, Korf BR (eds): Principles and Practice of Medical Genetics, ed 5. Edinburgh, Churchill Livingstone, 2007, pp 2817-2850.
3. Korf BR, Rubenstein AE: Neurofibromatosis: A Handbook for Patients, Families, and Health Care Professionals. New York, Thieme Medical Publishers, 2005.
4. Tinschert S: Clinical phenotypes in patients with NF1 microdeletions; in Kaufmann D (ed): Neurofibromatoses. Monogr Hum Genet 2008;16:78-88.
5. Upadhyaya M, Huson SM, Davies M, Thomas N, Giovannini S, et al: A complete absence of cutaneous neurofibromas associated with a 3-bp in-frame deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): A clinically significant genotype-phenotype correlation? Am J Hum Genet 2007;80:140-151. (Pubitemid 46047657)
6. Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, et al: Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis type 1-like phenotype. Nat Genet 2007;39:1120-1126. (Pubitemid 47340658)
7. MacCollin M, Chiocca EA, Evans DG, Friedman JM, Horvitz R, et al: Diagnostic criteria for schwannomatosis. Neurology 2005;64:1838-1845. (Pubitemid 40800695)
8. Hulsebos T J M, Plomp AS, Wolterman RA, Robanus-Maandag Els C, Baas F, Wesseling P: Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 2007;80:805-810. (Pubitemid 46564417)
9. Bentires-Alj M, Kontardis MI, Neel BG: Stops along the RAS pathway in human genetic disease. Nat Med 2006;12:283-285. (Pubitemid 43355073)
10. Denayer E, Legius E: What's new in the neuro-cardio-facial-cutaneous syndromes? Eur J Pediatr 2007;431:535-537.
11. Stevenson DA, Swensen JJ, Viskochil DH: Neurofibromatosis type 1 and other syndromes of the Ras pathway; in Kaufmann D (ed): Neurofibromatoses. Monogr Hum Genet 2008;16:32-45.
12. Stumpf D: Consensus development conference of neurofibromatosis. Arch Neurol 1988;45:575-578.
13. Riccardi VM: Neurofibromatosis; clinical heterogeneity. Curr Prob Cancer 1982;VII:1-34.
14. Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans D G R: Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 2002;59:1759-1765. (Pubitemid 35424459)
15. Viskochil DH, Carey JC: Nosological considerations of the neurofibromatoses. J Dermatol 1992;19:873-880. (Pubitemid 23119664)
16. Allanson JE, Upadhyaya M, Watson GH, Partington M, Lakey D, et al: Watson syndrome: Is it a sub-type of neurofibromatosis? J Med Genet 1991;28:752-756.
17. Ruggieri M, Huson SM: The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 2001;56:1433-1443. (Pubitemid 32532254)
18. Maertens O, De Schepper S, Van De Sompele J, Brems H, Heyns I, et al: Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am J Hum Genet 2007;81:243-251. (Pubitemid 47236073)
19. Evans D G R, Wallace A: NF2: mutations and management of disease; in Kaufmann D (ed): Neurofibromatoses. Monogr Hum Genet 2008;16:154-166.
20. Kluwe L: Molecular studies on Schwannomatosis; in Kaufmann D (ed): Neurofibromatoses. Monogr Hum Genet 2008;16:177-188.
21. Huson SM, Harper PS, Compston D A S: Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 1988;111:1355-1381. (Pubitemid 19028458)
22. Listernick R, Louis DN, Packer RJ, Gutmann DH: Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997;41:143-149. (Pubitemid 27082094)
23. Riccardi VM, Eichner JE: Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Baltimore, Johns Hopkins University Press, 1992.
24. De Smet L, Sciot R, Legius E: Multifocal glomus tumours in the fingers of two patients with neurofibromatosis type 1. J Med Genet 2002;39:e45.
25. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A: Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002;39:311-314. (Pubitemid 34526349)
26. Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, et al: Women with neurofibromatosis 1 are at moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 2007;44:481-484. (Pubitemid 47325733)
27. Messiaen LM, Callens T, Mortier G, Beysen D, Van Den Broucke I, et al: Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000;15:541-555. (Pubitemid 30368440)
28. Scott RH, Mansour S, Pritchard-Jones K, Kumar D, MacSweeney F, Rahman N: Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations. Nat Clin Pract Oncol 2007;4:130-134. (Pubitemid 46189541)
29. Bandipalliam P: Syndrome of early onset colon cancers, hematologic malignancies and features of neurofibromatosis in HNPCC families with homozygous mismatch repair mutations. Fam Cancers 2005;4:323-333. (Pubitemid 41795810)
30. Pratt CB, Parham DM, Rao BN, Fleming ID, Dilawari R: Multiple colorectal carcinomas, polyposis coli, and neurofibromatosis. J Natl Cancer Inst 1988;80:1170-1172.
31. Wang Q, Montmain G, Ruano E, Upadhyaya M, Dudley S, et al: Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Hum Genet 2003;112:117-123. (Pubitemid 36869093)
32. Gutmann DH, Winkeler E, Kabbarah O, Hedrick N, Dudley S, et al: Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. Oncogene 2003;22:4581-4585. (Pubitemid 36920702)
33. Stevenson DA, Viskochil DH, Schorry EK, Crawford AH, D'Astous J, et al: The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1. Genet Med 2007;9:409-412. (Pubitemid 47222133)
34. Upadhyaya M: NF1 gene structure and NF1 genotype/phenotype correlations; in Kaufmann D (ed): Neurofibromatoses. Monogr Hum Genet 2008;16:46-62.
35. Easton DF, Ponder MA, Huson SM, Ponder B A J: An analysis of variation in expression of NF1:evidence for modifying genes. Am J Hum Genet 1993;53:305-315.
36. Consoli C, Moss C, Green S, Balderson D, Cooper DN, Upadhyaya M: Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1. J Invest Dermatol 2005;125:463-466.
37. Tinschert S, Naumann I, Stegmann E, Buske A, Kaufmann D, et al: Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet 2000;8:455-459. (Pubitemid 30364826)
38. Schultz ES, Kaufmann D, Tinschert S, Schell H, Von Den Driesch P, Schuler G: Segmental neurofibromatosis. Dermatology 2002;204:296-297. (Pubitemid 34665149)
39. Charrow J, Listernick R, Ward K: Autosomal dominant multiple café-au-lait spots and neurofibromatosis 1: evidence of non-linkage. Am J Med Genet 1993;45:606-608. (Pubitemid 23066426)
40. Brunner HG, Hulsebos T, Steijlen PM, der Kinderen DJ, Vd Steen A, Hamel BC: Exclusion of the neurofibromatosis 1 locus in a family with inherited café-au-lait spots. Am J Med Genet 1993;46:472-474. (Pubitemid 23149698)
41. Abeliovich D, Gelman-Kohan Z, Silverstein S, Lerer I, Chemke J, et al: Familial café-au-lait spots: a variant of neurof ibromatosis type 1. J Med Genet 1995;32:985-986.
42. Watson GH: Pulmonary stenosis, cafe-au-lait spots, and dull intelligence. Arch Dis Child 1967;42:303-307.
43. Allanson JE, Upadhyaya M, Watson GH, Partington M, MacKenzie A, et al: Watson syndrome: is it a subtype of type 1 neurofibromatosis? J Med Genet 1991;2811:752-756. (Pubitemid 21922545)
44. Tassabehji M, Strachan T, Sharland M, Colley A, Donnai D, et al: Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome. Am J Hum Genet 1993;53:90-95. (Pubitemid 23313739)
45. Upadhyaya M, Shen M, Cherryson A, Farnham J, Maynard J, et al: Analysis of mutations at the neurofibromatosis 1 (NF1) locus. Hum Mol Genet 1992;1:735-740.
46. Opitz JM, Weaver DD: The neurofibromatosis-Noonan syndrome. Am J Med Genet 1985;21:477-490.
47. Colley A, Donnai D, Evans DG: Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis. Clin Genet 1996;49:59-64. (Pubitemid 26116815)
48. Tullu MS, Muranjan MN, Kantharia VC, Parmar RC, Sahu DR, et al: Neurofibromatosis-Noonan syndrome or LEOPARD syndrome? A clinical dilemma. J Postgrad Med 2000;46:98-100.
49. Baralle D, Mattocks C, Kalidas K, Elmslie F, Whittaker J, et al: Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndrome (NFNS). Am J Med Genet 2003;119:1-8. (Pubitemid 37063906)
50. Ars E, Kruyer H, Gaona A, Casquero P, Rosell J, et al: A clinical variant of neurofibromatosis type one: familial spinal neurofibromatosis. Am J Hum Genet 1998;62:834-841. (Pubitemid 28194325)
51. Poyhonen M, Leisti E-L, Kytolo S, Leist J: Hereditary spinal neurofibromatosis: a rare form of NF1? J Med Genet 1997;34:184-187. (Pubitemid 27107637)
52. Pulst SM, Riccardi VM, Fain P, Korenberg JR: Familial spinal neurofibromatosis: clinical and DNA linkage analysis. Neurology 1991;41:1923-1927.
53. Messiaen L, Callens T, Williams JB, Babovic-Vuksanovic D, Huson S, et al: Genotype-phenotype correlations in spinal NF. Poster presentation, Am Soc Hum Genet 2007.
54. Huson SM, Compston DA, Harper PS: A genetic study of von Recklinghausen neurof ibromatosis in south east Wales. II. Guidelines for genetic counselling. J Med Genet 1989;26:712-721. (Pubitemid 19270600)
55. Korf BR: Diagnostic outcome in children with multiple café au lait spots. Pediatrics 1992;90:924-927.
56. Tucker T, Wolkenstein P, Reviz J, Zeller J, Friedman JM: Association between benign and malignant nerve sheath tumors in NF1. Neurology 2005;65:205-211. (Pubitemid 41022362)